Cancer Therapies
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
512
NCT06507306
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 3, 2024
Completion: Jan 31, 2027
NCT06645886
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies
Start: Dec 9, 2024
Completion: Feb 29, 2028
NCT06720987
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Start: Feb 4, 2025
Completion: Jun 30, 2030
NCT06994806
A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Start: Jun 24, 2025
Completion: May 31, 2028
NCT07207707
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
Start: Sep 16, 2025
Completion: Mar 31, 2027
Loading map...